Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nix

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Molecular Cancer Therapeutics|September 23, 2018
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug ConjugatesChristopher S Neumann, Kathleen C Olivas, Martha E Anderson, et al.
Journal of Synchrotron Radiation|June 18, 2025
ALS-ENABLE: creating synergy and opportunity at the Advanced Light Source synchrotron structural biology beamlinesCorie Y Ralston, Sayan Gupta, Joshua T Del Mundo, et al.
Trials|March 19, 2026
TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): study protocol for a stepped-wedge, cluster-randomized clinical trialP D W D De Zoysa, S A Weerasinghe, J Gamage, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Cell|September 29, 2020
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyLuca Piccoli, Young-Jun Park, M Alejandra Tortorici, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Molecular Cancer Therapeutics|September 23, 2018
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug ConjugatesChristopher S Neumann, Kathleen C Olivas, Martha E Anderson, et al.
Journal of Synchrotron Radiation|June 18, 2025
ALS-ENABLE: creating synergy and opportunity at the Advanced Light Source synchrotron structural biology beamlinesCorie Y Ralston, Sayan Gupta, Joshua T Del Mundo, et al.
Trials|March 19, 2026
TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): study protocol for a stepped-wedge, cluster-randomized clinical trialP D W D De Zoysa, S A Weerasinghe, J Gamage, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Cell|September 29, 2020
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyLuca Piccoli, Young-Jun Park, M Alejandra Tortorici, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Pageof 10